(2e,4e,7z)-2,4,7-Decatrienal
| Common Name: |
(2e,4e,7z)-2,4,7-Decatrienal |
| IUPAC Name: |
(2E,4E,7Z)-deca-2,4,7-trienal |
| Molecular Formula: |
C10H14O |
| SMILES: |
CCC=CCC=CC=CC=O |
| Inchi: |
1S/C10H14O/c1-2-3-4-5-6-7-8-9-10-11/h3-4,6-10H,2,5H2,1H3/b4-3-,7-6+,9-8+ |
| Inchi Key: |
KEXCNWISTVJVBV-YPVUHSJLSA-N |
| Cas No: |
66642-86-2 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
1 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
2 |
| Name |
Value |
| Molecular Weight (g/mol) |
150.22 |
| Mass (g/mol) |
150.104 |
| Molar Refractivity |
48.96 |
| Net Charge |
|
| HBD |
|
| HBA |
1 |
| Rt Bonds |
5 |
| Rings |
|
| TPSA |
17.07 |
| Hetero Atoms |
1 |
| Heavy Atoms |
11 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
258.00 to 259.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.013 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.30 |
| LogP |
2.654 |
| iLOGP |
2.56 |
| XLOGP3 |
2.56 |
| WLOGP |
2.65 |
| MLOGP |
2.40 |
| ESOL Log S |
-2.05 |
| ESOL Solubility (mg/ml) |
1.33 |
| ESOL Solubility (mol/l) |
0.009 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-2.57 |
| Ali Solubility (mg/ml) |
0.41 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
-1.28 |
| Silicos-IT Solubility (mg/ml) |
7.96 |
| Silicos-IT Solubility (mol/l) |
0.05 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-5.40 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.54 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.63 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
